GlassScriptPrepare for your visit
Ajit Gubbi
Gynecologic Oncology · Cincinnati, OH · NPI 1023273687
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$12,478.37
in general payments reported to CMS, 2019-2025 · $480 in 2025
The $480 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Who reported paying
General payments only, top 6 by amount.
- Seagen INC. $8,444.65
- Astrazeneca Pharmaceuticals LP $2,910.63
- Merck Sharp & Dohme LLC $239.87
- Janssen Biotech, INC. $174.65
- Clovis Oncology, INC. $120.70
- Novartis Pharmaceuticals Corporation $78.58
Drugs and devices associated with these payments
Keytruda Lynparza Lenvima Enhertu Verzenio Jaypirca Orserdu Jemperli Zejula Rezlidhia Gavreto Tavalisse
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ajit Gubbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/272856/ajit-gubbi